Funding

  1. Showing 138 results for:
  2. Funding
All Subjects

Regione Sicilia

Published by REGIONE SICILIA

Basic ResearchClinical ResearchPreclinical ResearchPublic

The OP ERDF Sicily 2014/2020 was built on the basis of an analysis of the relevant needs, problems and opportunities that characterize the Sicilian Region with the involvement of the territory through a path of public consultation. The thematic objectives and investment priorities have been identified on the basis of EU Regulations n. 1301/2013 and n. 1303/2013 and the Partnership Agreement for Italy 2014/2020.

View this resource Bookmark this resource

Sanofi Innovation Awards iAwards Europe

Published by SANOFI

AwardBasic ResearchClinical ResearchPreclinical ResearchPrivate

Launched in the US three years ago, Sanofi’s Innovation Awards (iAwards) program is now expanding into Europe. Developed in response to the continuing rise of chronic diseases worldwide, the iAwards aim to promote scientific breakthroughs by tapping into the world’s greatest minds through close collaboration with renowned academic institutions.

View this resource Bookmark this resource

BRIDGE HEAD

Published by EIT

Clinical ResearchIndustrial Development or SMEPreclinical ResearchPublic

This is an internationalisation programme for start-ups interested in being hosted by one or more top-notch Accelerators or Incubators/clusters from the EIT Health European network. Start-ups travel to accelerators of their choice to speed up access to markets, tap into local networks of partners and clients, access infrastructure and get a first-hand feeling for the local regulatory and business context.

View this resource Bookmark this resource

Clinical Studies of Orphan Products Addressing Unmet Needs of Rare Diseases

Published by NIH

Clinical Trial

The purpose of this funding opportunity announcement (FOA) is to fund clinical trials of products evaluating efficacy and/or safety in support of a new indication or change in labeling to address unmet needs in rare diseases or conditions. Additionally, through the funding of collaborative, efficient, and/or innovative clinical trials, FDA expects to increase the number of approved treatments for rare diseases and exert a broad and positive impact on rare disease drug development.

View this resource Bookmark this resource

Pilot Projects Investigating Understudied Proteins Associated with Rare Diseases

Published by NIH

Druggable ProteinPilot

The purpose of this funding opportunity announcement (FOA) is to solicit applications for pilot projects to elucidate a role for understudied proteins associated with rare diseases. Awards will support generation of preliminary data and/or tools around eligible understudied protein(s). A list of eligible proteins is provided and are members of druggable protein families that have a known association with a rare disease. This FOA is intended to jumpstart research on understudied proteins that are associated with rare diseases and provide applicants with sufficient funding to perform basic biochemical and/or biological work to further the characterization of understudied proteins associated with rare disease.

View this resource Bookmark this resource

Clinical Trial Readiness for Rare Neurological and Neuromuscular Diseases

Published by NIH

Clinical Trial ReadinessNeuromuscular

This Funding Opportunity Announcement (FOA) invites researchers to submit applications for support of clinical studies that address critical needs for clinical trial readiness in rare neurological and neuromuscular diseases. These studies should result in clinically validated biomarkers and clinical outcome assessment measures appropriate for use in upcoming clinical trials. Through the support of trial readiness studies, NINDS expects to enhance the quality and increase the likelihood of success of clinical trials in these rare diseases.

View this resource Bookmark this resource